AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject has been …
!["Pancreatic Cancer Treatment"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/erasmus-mc-cover.jpg?resize=600%2C400&ssl=1)
!["Pancreatic Cancer Treatment"](https://i0.wp.com/globalpharmalive.com/wp-content/uploads/2024/02/erasmus-mc-cover.jpg?resize=600%2C400&ssl=1)
Pharma News From Around The World
Pharma News From Around The World
Pharma News From Around The World
AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the first subject has been …